Ads
related to: biotechnology
Search results
CollPlant Biotechnologies First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 1 day agoCollPlant Biotechnologies (NASDAQ:CLGN) First Quarter 2024 Results Key Financial Results Revenue:...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks via Yahoo Finance· 1 day agoThe iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded...
Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
Benzinga via Yahoo Finance· 18 hours agoOn Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2...
Vir stock gains on hepatitis drug data (NASDAQ:VIR)
Seeking Alpha· 1 day agoVir Biotechnology (VIR) stock gains as its hepatitis therapy tobevibart developed with Xencor shows early signs of efficacy in a Phase 2 trial. Read more...
Putin’s Elusive Daughters Are Thrust Into the Limelight
The Daily Beast via Yahoo News· 4 hours agoOn Wednesday, the sisters spoke at the St. Petersburg International Economic Forum (SPIEF), a summit...
Peapack Gladstone Financial Corp Sells 143 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 hours ago(NASDAQ:BIIB – Free Report) by 4.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,813 shares ...
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Zacks via Yahoo Finance· 2 days agoThe First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively...
MAIA Biotechnology reports promising Phase 2 trial results By Investing.com
Investing.com· 2 days agoMAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company, has...
Antisense that delivers - Nature Biotechnology
Nature· 18 hours agoThis Month in Biotechnology Published: January 1999 Antisense that delivers Andrew Marshall 1 Nature Biotechnology volume 17 , page 10 ( 1999 ) Cite this ...
Researchers identify a key metabolic gene as target for improved cancer immunotherapy
Medical Xpress· 14 minutes agoInhibiting this gene through pharmacologic or genetic intervention led to better T-cell infiltration, increasing effectiveness of immunotherapy in a type of pancreatic cancer called PDAC. The ...